KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Asset Writedowns and Impairment (2016 - 2019)

Historic Asset Writedowns and Impairment for Astrana Health (ASTH) over the last 10 years, with Q3 2019 value amounting to $2.0 million.

  • Astrana Health's Asset Writedowns and Impairment changed N/A to $2.0 million in Q3 2019 from the same period last year, while for Jun 2020 it was $2.0 million, marking a year-over-year decrease of 2102.97%. This contributed to the annual value of $422000.0 for FY2023, which is N/A changed from last year.
  • As of Q3 2019, Astrana Health's Asset Writedowns and Impairment stood at $2.0 million.
  • Over the past 5 years, Astrana Health's Asset Writedowns and Impairment peaked at $3.9 million during Q4 2018, and registered a low of -$2.3 million during Q2 2019.
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $164064.5 (2016), whereas its average is $451671.4.
  • Per our database at Business Quant, Astrana Health's Asset Writedowns and Impairment tumbled by 9603.45% in 2017 and then surged by 28486.13% in 2019.
  • Quarter analysis of 5 years shows Astrana Health's Asset Writedowns and Impairment stood at $126367.0 in 2015, then grew by 27.12% to $160633.0 in 2016, then crashed by 48.08% to $83395.0 in 2017, then surged by 4562.15% to $3.9 million in 2018, then tumbled by 48.71% to $2.0 million in 2019.
  • Its Asset Writedowns and Impairment stands at $2.0 million for Q3 2019, versus -$2.3 million for Q2 2019 and $951000.0 for Q1 2019.